Reeses Onetab Cold And Flu
NDC Package 10956-813-01
Package Information
Reeses Onetab Cold And Flu is temporarily relieves symptoms associated with the common cold, flu, hay fever and other respiratory allergiesnasal and sinus congestion itching of the nose or throatminor aches and painssneezing and runny noseitchy, watery eyesheadaches. Marketed by Reese Pharmaceutical Co., this product is identified by NDC 10956-813 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 1147619 - acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG Oral Tablet
- RxCUI: 1147619 - acetaminophen 650 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 10 MG Oral Tablet
- RxCUI: 1147619 - APAP 650 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10956 - Reese Pharmaceutical Co.
- 10956-813 - Reeses Onetab Cold And Flu
- 10956-813-01 - 1 BOTTLE, PLASTIC in 1 CARTON / 30 TABLET in 1 BOTTLE, PLASTIC (10956-813-30)
- 10956-813 - Reeses Onetab Cold And Flu
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10956-813-01 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 30 tablet in 1 bottle, plastic (10956-813-30) of Reeses Onetab Cold And Flu, labeled by Reese Pharmaceutical Co.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Reese Pharmaceutical Co. on April 05, 2010. The current certification is valid through December 31, 2018.
How is this Reese Pharmaceutical Co. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10956081301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.